The revenue of the cell-based assays market in 2017 is estimated at $13bn and is expected to grow at a CAGR of 9.2% in the first half of the forecast period. Visiongain estimated that the consumables and services segments accounted for 74.26% of the market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 241-page report you will receive 85 tables and 103 figures– all unavailable elsewhere.
The 241-page report provides clear detailed insight into the cell-based assays market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Cell-based Assays market forecasts from 2018-2028
• Cell-Based Assays Market by Product Type:
• Instrument
• Consumables
• Software
• Services
• Reagents
• Assay Kits
• Microplates
• Cell Lines
• Probes & Labels
• Cell-Based Assays Market by Application:
• Drug Discovery
• Basic Research
• Predictive Technology
• Cell-based Assays Market by End-User:
• Pharma & Biotech Companies
• Academic Institutes
• CROs
• This report provides individual revenue forecasts to 2028 for these national markets:
• US
• Japan
• Germany
• UK
• France
• Spain
• Italy
• China
• India
• Russia
• Brazil
• Our study includes SWOT and STEP analysis of the cell-based assays market.
• Our study discusses the selected leading companies that are the major players in the cell-based assays market:
• BD (Becton, Dickinson and Company)
• BioAgilytix Labs
• BioVision
• Cell Assay Innovations, Inc.
• Charles River Laboratories International
• CYTOO SA
• DiscoverX
• GE Healthcare
• InSphero
• Marin Biological Laboratories
• Molecular Devices
• Perkin Elmer
• Pharmaceutical Product Development
• Porsolt
• Promega
• ProQinase GmbH
• QGel
• SGS Group, Inc.
• Thermo Fisher Scientific (and Affymetrix acquisition)
• This report also discusses technology, trends and future outlook of the cell-based assays industry
Visiongain’s study is intended for anyone requiring commercial analyses for the cell-based assays market. You find data, trends and predictions.
Buy our report today Cell-Based Assays World Industry and Market 2018-2028: Drug Discovery, Basic Research, Predictive Technology, Instrument, Consumables, Software, Services, Reagents, Assay Kits, Microplates, Cell Lines, Probes & Labels, Pharma & Biotech Companies, Academic Institutes, CROs.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 Cell-Based Assays Overview
1.2 Cell-Based Assays Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Questions Answered by this Report
1.6 Who is this Report for?
1.7 Research Methods and Analysis
1.8 Frequently Asked Questions
1.9 Associated Reports
1.10 About Visiongain
2. Introduction to Cell-Based Assays and Applications
2.1 Cost of New Drug Discovery and Development Reaches $2.6bn – Companies Constantly Looking for Increased Efficiencies
2.2 Drug Discovery Approaches – Target-Based and Phenotype-Based Discovery
2.3 Drug Screening Assays
2.4 Animal Models Present In Vivo Conditions: But Do Results Translate to Humans?
2.5 Biochemical Assays and their Advantages over Animal Models
2.5.1 Applications of Biochemical Assays
2.5.2 Lead Identification and Toxicity Testing
2.6 Cell-Based Assays and their Advantages
2.7 2D vs 3D Cell-Based Assays
2.8 Advanced Cell-Based Assays
2.9 The Different Assay Detection Methods and Technologies
2.10 Cells used in Cell-Based Assays
2.10.1 Immortalised Cell Lines – Convenient but not Truly Representative of Normal Human Cell Lines
2.10.2 Primary Cells: Closer to the In Vivo Environment
2.10.3 Stem Cells: Potential to Overcome Limitations of Primary cells and Immortalised Cell Lines
2.11 Uses for Cell-Based Assays in Drug Discovery and Development
2.11.1 Target Validation
2.11.2 Primary Screening
2.11.3 Secondary Screening
2.11.4 ADME Screening
2.11.5 High Throughput Screening: Greatly Increases Efficiency
3. World Cell-Based Assays Market 2018-2028
3.1 Global Cell-Based Assays Market Forecast 2018-2028
3.2 Drivers for the Cell-Based Assays Market
3.2.1 Growing incidence of chronic diseases
3.2.2 Increasing R&D investment in drug discovery research
3.2.3 Growing adoption of high-throughput screening methodologies
3.2.4 Rapid technological advancements
3.3 Restraints for the Cell-Based Assays Market
3.3.1 High cost of instruments
3.3.2 Dearth of skilled professionals
3.4 Opportunities
3.4.1 Emerging countries to offer lucrative growth opportunities
3.4.2 Growing adoption of label-free cell-based assays
3.5 Trends
3.5.1 3D cell cultures
3.5.2 Microplate readers for cell-based assays
3.6 Cell-Based Assays Market by Products Type: Forecasts 2018-2028
3.6.1 Instrument Segment Forecasts 2018-2028
3.6.1.1 Equipment Needed to Conduct Cell-Based Assays
3.6.2 Consumables Forecasts 2018-2028
3.6.2.1 Reagents Forecasts 2018-2028
3.6.2.2 Assay kits Forecasts 2018-2028
3.6.2.3 Microplates Forecasts 2018-2028
3.6.2.4 Cell lines Forecasts 2018-2028
3.6.2.5 Probes and labels Forecasts 2018-2028
3.6.3 Software Forecasts 2018-2028
3.6.4 Services Forecasts 2018-2028
3.7 Cell-Based Assays Market by Application: Forecasts 2018-2028
3.7.1 Drug Discovery Forecasts 2018-2028
3.7.2 Basic Research Forecasts 2018-2028
3.7.3 Predictive Technology Forecasts 2018-2028
3.8 Cell-based Assays Market by End-User: Forecasts 2018-2028
3.8.1 Pharma & Biotech Companies Forecasts 2018-2028
3.8.2 Academic Institutions Forecasts 2018-2028
3.8.3 Contract Research Organizations (CROs) Forecasts 2018-2028
4. Leading National Markets for Cell-Based Assays, 2018-2028
4.1 Regional Breakdown of the Global Cell-Based Assays Market, 2018-2028
4.2 Global Cell-Based Assays market: Regional Forecast 2017-2028
4.3 The US Cell-Based Assays Revenue Forecast 2018-2028
4.4 European Union (EU) Cell-Based Assays Market 2018-2028
4.4.1 IMI’s Pan-European Drug Discovery Platform holds Much Promise
4.4.2 EU National Market Share Breakdown, 2017, 2023 and 2028
4.4.3 EU Market: Main National Forecasts, 2018-2028
4.4.4 German Cell-Based Assay Revenue Forecast, 2018-2028
4.4.5 French Cell-Based Assays Revenue Forecast, 2018-2028
4.4.6 UK Cell-Based Assays Revenue Forecast, 2018-2028
4.4.7 Spanish Cell-Based Assays Revenue Forecast, 2018-2028
4.4.8 Italian Cell-Based Assays Revenue Forecast, 2018-2028
4.5 Japanese Cell-Based Assays Revenue Forecast, 2018-2028
4.6 BRIC Nations (Brazil, Russia, India and China) Cell-Based Assays Market
4.6.1 BRIC Countries National Breakdown, 2017, 2023 and 2028
4.6.2 BRIC Countries National Forecasts, 2018-2028
4.6.3 Chinese Cell-Based assay Revenue Forecast, 2018-2028
4.6.4 Indian Cell-Based Assays Revenue Forecast, 2018-2028
4.6.5 Russian Cell-Based Assays Revenue Forecast, 2018-2028
4.6.6 Brazilian Cell-Based Assays Revenue Forecast, 2018-2028
5. Leading Companies in the Cell-Based Assays Market, 2017
5.1 DiscoverX Corporation (Eurofins)
5.1.1 Business Overview
5.1.2 Company Snapshot
5.1.3 DiscoverX: Cell-based Assay Product Portfolio
5.1.4 DiscoverX: Financial Overview
5.1.5 DiscoverX: Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Business Overview
5.2.2 Company Snapshot
5.2.3 Thermo Fisher Scientific: Cell-based Assay Product Portfolio
5.2.4 Thermo Fisher Scientific: Financial Overview
5.2.5 Thermo Fisher Scientific: Recent Developments
5.3 Cell Assay Innovations, Inc.
5.3.1 Business Overview
5.3.2 Company Snapshot
5.3.3 Cell Assay Innovations: Cell-based Assay Product Portfolio
5.3.4 Cell Assay Innovations: Recent Developments
5.4 InSphero AG
5.4.1 Business Overview
5.4.2 Company Snapshot
5.4.3 InSphero AG: Cell-based Assay Product Portfolio
5.4.4 InSphero AG: Recent Developments
5.5 QGel SA.
5.5.1 Business Overview
5.5.2 Company Snapshot
5.5.3 QGel SA.: Cell-based Assay Product Portfolio
5.5.4 QGel SA.: Recent Developments
5.6 Becton, Dickinson and Company
5.6.1 Business Overview
5.6.2 Company Snapshot
5.6.3 BD.: Cell-based Assay Product Portfolio
5.6.4 BD: Financial Overview
5.6.5 BD: Recent Developments
5.7 Promega Corporation
5.7.1 Business Overview
5.7.2 Company Snapshot
5.7.3 Promega: Cell-based Assay Product Portfolio
5.7.4 Promega Corporation: Recent Developments
5.8 BioVision, Inc.
5.8.1 Business Overview
5.8.2 Company Snapshot
5.8.3 BioVision, Inc.: Cell-based Assay Product Portfolio
5.8.4 BioVision, Inc.: Recent Developments
5.9 Marin Biologic Laboratories
5.9.1 Business Overview
5.9.2 Company Snapshot
5.9.3 Marin Biologic: Cell-based Assay Product Portfolio
5.10 Molecular Devices, LLC. (Danaher Corporation)
5.10.1 Business Overview
5.10.2 Company Snapshot
5.10.3 Molecular Devices, LLC: Cell-based Assay Product Portfolio
5.10.4 Danaher Corporation: Financial Overview
5.10.5 Molecular Devices, LLC.: Recent Developments
5.11 Porsolt
5.11.1 Business Overview
5.11.2 Company Snapshot
5.11.3 Porsolt: Cell-based Assay Product Portfolio
5.11.4 Porsolt: Recent Developments
5.12 CYTOO SA
5.12.1 Business Overview
5.12.2 Company Snapshot
5.12.3 CYTOO SA: Cell-based Assay Product Portfolio
5.12.4 CYTOO SA: Recent Developments
5.13 Pharmaceutical Product Development, LLC.
5.13.1 Business Overview
5.13.2 Company Snapshot
5.13.3 Pharmaceutical Product Development, LLC: Cell-based Assay Product Portfolio
5.13.4 Pharmaceutical Product Development, LLC.: Recent Developments
5.14 ProQinase GmbH
5.14.1 Business Overview
5.14.2 Company Snapshot
5.14.3 ProQinase GmbH: Cell-based Assay Product Portfolio
5.15 Charles River Laboratories International, Inc.
5.15.1 Business Overview
5.15.2 Company Snapshot
5.15.3 Charles River Laboratories International, Inc.: Cell-based Assay Product Portfolio
5.15.4 Charles River Laboratories International, Inc.: Financial Overview
5.15.5 Charles River Laboratories: Recent Developments
5.16 BioAgilytix Labs
5.16.1 Business Overview
5.16.2 Company Snapshot
5.16.3 BioAgilytix Labs: Cell-based Assay Product Portfolio
5.16.4 BioAgilytix Labs: Recent Developments
5.17 SGS Group
5.17.1 Business Overview
5.17.2 Company Snapshot
5.17.3 SGS Group: Cell-based Assay Product Portfolio
5.17.4 SGS Group, Inc.: Financial Overview
5.17.5 SGS Group: Recent Developments
5.18 Perkin Elmer Inc.
5.18.1 Business Overview
5.18.2 Company Snapshot
5.18.3 Perkin Elmer: Cell-based Assay Product Portfolio
5.18.4 Perkin Elmer: Financial Overview
5.18.5 Perkin Elmer: Recent Developments
5.19 General Electric Company (GE Healthcare)
5.19.1 Business Overview
5.19.2 Company Snapshot
5.19.3 General Electric Company.: Cell-based Assay Product Portfolio
5.19.4 General Electric Company: Financial Overview
5.19.5 General Electric Company: Recent Developments
6. Cell-Based Assays Technology, Trends and Future Outlook
6.1 Stem Cells: Vast Potential
6.1.1 The Benefits of Using Stem Cells in Cell-Based Assays
6.1.2 iPSCs: An Uncontroversial and Abundant Source
6.1.3 Companies Providing Stem Cell-Based Assays
6.2 Toxicity Testing: Important Field for Cell-Based Assays
6.3 3D Systems: The Advantages of Next Generation of Cell Systems
6.3.1 Complexity of 3D Systems is a Challenge but More are Reaching the Market
6.3.2 Organoids – The Future of Drug Development
6.3.2.1 Hurdles to the Future Organoid Market
6.3.2.2 Organoids Now and in the Future
6.3.3 Bio-Printing for Drug Development: Using 3D Printing Technology
6.4 Increasing Outsourcing of Cell-Based Assays
6.5 Label-Free Technology
6.6 GPCRs: A Common Drug and Drug Discovery Target
6.6.1 GPCRs in Cell-Based Assays
6.6.2 Allosteric GPCRs
6.7 Increasing Miniaturisation and Automation
6.7.1 Advantages of Miniaturisation
6.7.2 Advantages of Automation
6.8 Microfluids are Set to be a Trend
6.8.1 The Potential Challenges to Microfluids
6.9 Multiplexing: Improves Efficiency of cell-Based Assays
6.9.1 Advantages will Drive Growth
6.10 High Content Screening: A Well-Established Tool
6.10.1 The Future for HCS: Will Continue to Expand, Still Room for Innovation
6.11 Cell-Based Assays for the Development of Biologics
7. Qualitative Analysis of the Cell-Based Assays Market, 2017
7.1 SWOT Analysis of the Cell-Based Assays Market
7.1.1 Strengths Within the Cell-Based Assay Market
7.1.2 Weaknesses Within the Cell-Based Assays Market
7.1.3 Opportunities for the Cell-Based Assays Market
7.1.4 Threats to the Cell-Based Assays Market
7.2 STEP Analysis of the Cell-Based Assays Market
7.2.1 Social Factors
7.2.2 Technological Factors
7.2.3 Economic Factors
7.2.4 Political Factors
8. Conclusions from the Research and Analysis
8.1 Growth Has Been Driven by Advantages of Cell-Based Assays
8.2 Current Status of the Market and its Growth Drivers
8.3 The Most Dominant National Markets and Emerging Countries
8.4 Future Trends and Technology
Appendices
Associated Reports
Visiongain Report Sales Order Form
About Visiongain
Report Evaluation Form
List of Figures
Figure 1.1 Cell-Based Assays Market Segmented by Application
Figure 1.2 Cell-Based Assays Market Segmented by Product
Figure 1.2 Cell-Based Assays Market Segmented by End-User
Figure 2.1 Stages of Pre-Clinical Drug Development
Figure 3.1 Global Cell-Based Assays Market Forecast: Revenue ($m), 2017-2028
Figure 3.2 Estimated number of new lung cancer cases worldwide, 2012-2025
Figure 3.3 Estimated number of new pancreatic cancer cases worldwide, 2012-2025
Figure 3.4 R&D investment of phRMA members between 2011 and 2015
Figure 3.5 Drivers and Restraints for the Cell-Based Assays Market, 2018
Figure 3.6 Cell-Based Assays Market Segments Forecasts: Revenue ($m), 2017-2028
Figure 3.7 Cell-Based Assays Market Segments: Instruments Forecast - Revenue ($m), 2017-2028
Figure 3.8 Cell-Based Assays Market Segments: Instruments Forecast -AGR (%), 2017-2028
Figure 3.9 Cell-Based Assays Market Segments: Consumables Forecast - Revenue ($m), 2017-2028
Figure 3.10 Cell-Based Assays Market Segments: Consumables Forecast -AGR (%), 2017-2028
Figure 3.11 Cell-Based Assays Market Segments: Reagents Forecast -AGR (%), 2017-2028
Figure 3.12 Cell-Based Assays Market Segments: Reagents Forecast -AGR (%), 2017-2028
Figure 3.13 Cell-Based Assays Market Segments: Assay Kits Forecast - Revenue ($m), 2017-2028
Figure 3.14 Cell-Based Assays Market Segments: Assay Kits Forecast -AGR (%), 2017-2028
Figure 3.15 Cell-Based Assays Market Segments: Microplates Forecast - Revenue ($m), 2017-2028
Figure 3.16 Cell-Based Assays Market Segments: Microplates Forecast -AGR (%), 2017-2028
Figure 3.17 Cell-Based Assays Market Segments: Cell Lines Forecast - Revenue ($m), 2017-2028
Figure 3.18 Cell-Based Assays Market Segments: Cell Lines Forecast -AGR (%), 2017-2028
Figure 3.19 Cell-Based Assays Market Segments: Probes and Labels Forecast - Revenue ($m), 2017-2028
Figure 3.20 Cell-Based Assays Market Segments: Probes and Labels Forecast -AGR (%), 2017-2028
Figure 3.21 Cell-Based Assays Market Segments: Software Forecast - Revenue ($m), 2017-2028
Figure 3.22 Cell-Based Assays Market Segments: Software Forecast -AGR (%), 2017-2028
Figure 3.23 Cell-Based Assays Market Segments: Services Forecast - Revenue ($m), 2017-2028
Figure 3.24 Cell-Based Assays Market Segments: Services Forecast –AGR (%), 2017-2028
Figure 3.25 Cell-Based Assays Market Application Forecasts: Revenue ($m), 2017-2028
Figure 3.26 Drug Discovery Segment Forecast: Revenue ($m), 2017-2028
Figure 3.27 Drug Discovery Segment Forecast: AGR (%), 2017-2028
Figure 3.28 Basic Research Segment Forecast: Revenue ($m), 2017-2028
Figure 3.29 Basic Research Segment Forecast: AGR (%), 2017-2028
Figure 3.30 Predictive Technology Segment Forecast: Revenue ($m), 2017-2028
Figure 3.31 Predictive Technology Segment Forecast: AGR (%), 2017-2028
Figure 3.32 Cell-Based Assays Market End Users Forecasts: Revenue ($m), 2017-2028
Figure 3.33 Pharma & Biotech Companies Forecast: Revenue ($m), 2017-2028
Figure 3.34 Pharma & Biotech Companies Forecast: AGR (%), 2017-2028
Figure 3.35 Academic Institutes Forecast: Revenue ($m), 2017-2028
Figure 3.36 Academic Institutes Forecast: AGR (%), 2017-2028
Figure 3.37 CROs Forecast: Revenue ($m), 2017-2028
Figure 3.38 CROs Forecast: AGR (%), 2017-2028
Figure 4.1 Cell-Based Assays Market Breakdown by Region: Market Shares (%), 2017
Figure 4.2 Cell-Based Assays Market Breakdown by Region: Market Shares (%), 2023
Figure 4.3 Cell-Based Assays Market Breakdown by Region: Market Shares (%), 2028
Figure 4.4 Global Cell-Based Assays Market Regional Forecasts: Revenues ($m), 2017-2028
Figure 4.5 US Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
Figure 4.6 US Cell-Based Assays Market Forecast: AGR (%), 2017-2028
Figure 4.7 EU Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
Figure 4.8 EU Cell-Based Assays Market Forecast: AGR (%), 2017-2028
Figure 4.9 EU Market Breakdown by Nation: EU Market Shares (%), 2017
Figure 4.10 EU Market Breakdown by Nation: Market Shares (%), 2023
Figure 4.11 EU Market Breakdown by Nation: Market Shares (%), 2028
Figure 4.12 EU Market, Top National Forecasts: Revenue ($m), 2017-2028
Figure 4.13 German Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
Figure 4.14 German Cell-Based Assays Market Forecast: AGR (%), 2017-2028
Figure 4.15 French Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
Figure 4.16 French Cell-Based Assays Market Forecast: AGR (%), 2017-2028
Figure 4.17 UK Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
Figure 4.18 UK Cell-Based Assays Market Forecast: AGR (%), 2017-2028
Figure 4.19 Spanish Cell-Based Assays Market Forecast: Revenues($m), 2017-2028
Figure 4.20 Spanish Cell-Based Assays Market Forecast: AGR (%), 2017-2028
Figure 4.21 Italian Cell-Based Assays Market Forecast: Revenues($m), 2017-2028
Figure 4.22 Italian Cell-Based Assays Market Forecast: AGR (%), 2017-2028
Figure 4.23 Japanese Cell-Based Assays Market Forecast: Revenues($m), 2017-2028
Figure 4.24 Japanese Cell-Based Assays Market Forecast: AGR (%), 2017-2028
Figure 4.25 BRIC Countries Breakdown by Nation: Market Shares (%), 2017
Figure 4.26 BRIC Countries Breakdown by Nation: Market Shares (%), 2023
Figure 4.27 BRIC Countries Breakdown by Nation: Market Shares (%), 2028
Figure 4.28 BRIC Countries Breakdown by Nation: Revenues ($m), 2017-2028
Figure 4.29 Chinese Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
Figure 4.30 Chinese Cell-Based Assays Market Forecast: AGR (%), 2017-2028
Figure 4.31 Indian Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
Figure 4.32 Indian Cell-Based Assays Market Forecast: AGR (%), 2017-2028
Figure 4.33 Russian Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
Figure 4.34 Russian Cell-Based Assays Market Forecast: AGR (%), 2017-2028
Figure 4.35 Brazilian Cell-Based Assays Market Forecast: Revenue ($m), 2017-2028
Figure 4.36 Brazilian Cell-Based Assays Market Forecast: AGR (%), 2017-2028
Figure 5.1 Thermo Fisher Scientific: Net Revenues, 2015-2017 ($Million)
Figure 5.2 Thermo Fisher Scientific: Net Revenue by Segment, 2017
Figure 5.3 Thermo Fisher Scientific: Net Revenue by Geography, 2017
Figure 5.4 BD: Net Revenues, 2015-2017 ($Million)
Figure 5.5 BD: Net Revenue by Segment, 2017
Figure 5.6 BD: Net Revenue by Geography, 2017
Figure 5.7 Danaher Corporation: Net Revenues, 2015-2017 ($Million)
Figure 5.8 Danaher Corporation: Net Revenue by Segment, 2017
Figure 5.9. Danaher Corporation: Net Revenue by Geography, 2017
Figure 5.10 Charles River Laboratories: Net Revenues, 2015-2017 ($Million)
Figure 5.11 Charles River Laboratories: Net Revenue by Segment, 2017
Figure 5.12 Charles River Laboratories: Net Revenue by Geography, 2017
Figure 5.13 SGS Group: Net Revenues, 2015-2017 ($Million)
Figure 5.14 SGS Group: Net Revenue by Segment, 2017
Figure 5.15 SGS Group: Net Revenue by Geography, 2017
Figure 5.16 Perkin Elmer Inc.: Net Revenues, 2015-2017 ($Million)
Figure 5.17 Perkin Elmer: Segment Revenues, 2015-2017 ($Million)
Figure 5.18 General Electric Company: Net Revenues, 2015-2017 ($Million)
Figure 5.19 General Electric Company: Net Revenue by Segment, 2017
Figure 5.20 General Electric Company: Net Revenue by Geography, 2017
Figure 7.1 Strengths and Weaknesses of the Cell-Based Assay Market, 2017
Figure 7.2 Strengths and Weaknesses of the Cell-Based Assay Market, 2017
Figure 8.1 The Cell-Based Assay Submarket Revenue ($m) Breakdown by Products, 2017, 2023 and 2028
Figure 8.2 The Cell-Based Assay Submarket Revenue ($m) Breakdown by Application: Drug Discovery, Basic Research, and Predictive Technology 2017, 2023 and 2028
Figure 8.3 Regional Breakdown of the Cell-based Assay Market by Revenue ($m), 2017, 2023 and 2028
List of Tables
Table 2.1 Main Parameters Required in Drug Discovery and Development
Table 2.2 Selected Label-Free Detection Technologies Used for Cell-Based Assays
Table 2.3 Cell-Based Assays for HTS in Drug Screening
Table 3.1 Global Cell-Based Assays Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2017-2028
Table 3.2 Global Cell-Based Assays Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2017-2028
Table 3.3 Cell-Based Assays Market Segments: Instruments Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2017-2028
Table 3.4 Cell-Based Assays Market Segments: Consumables Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2017-2028
Table 3.5 Cell-Based Assays Market Segments: Reagents Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2017-2028
Table 3.6 Cell-Based Assays Market Segments: Assay Kits Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2017-2028
Table 3.7 Cell-Based Assays Market Segments: Microplates Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2017-2028
Table 3.8 Cell-Based Assays Market Segments: Cell Lines Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2017-2028
Table 3.9 Cell-Based Assays Market Segments: Probes and Labels Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2017-2028
Table 3.10 Cell-Based Assays Market Segments: Software Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2017-2028
Table 3.11 Cell-Based Assays Market Segments: Services Forecast- Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2017-2028
Table 3.12 Cell-Based Assays Market Application Forecasts: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2017-2028
Table 3.13 Drug Discovery Segment Forecast: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2017-2028
Table 3.14 Basic Research Segment Forecast: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2017-2028
Table 3.15 Predictive Technology Segment Forecast: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2017-2028
Table 3.16 Cell-Based Assays Market End-Users Forecasts: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2017-2028
Table 3.17 Pharma & Biotech Companies Forecast: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2017-2028
Table 3.18 Academic Institutes Forecast: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2017-2028
Table 3.19 CROs Forecast: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2017-2028
Table 4.1 Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2017
Table 4.2 Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2023
Table 4.3 Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2028
Table 4.4 Global Cell-Based Assays Market Regional Forecasts: Revenues ($m), AGR (%), CAGR (%), Market Shares (%), 2017-2028
Table 4.5 US Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), Market Shares (%), CAGR (%), 2017-2028
Table 4.6 EU Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), World Market Shares (%), CAGR (%), 2017-2028
Table 4.7 EU Market Breakdown by Leading Nation: EU Market Shares (%), Global Market Shares (%) and Revenues ($m), 2017
Table 4.8 EU Market Breakdown by Leading Nation: EU Market Shares (%), Global Market Shares (%) and Revenues ($m), 2023
Table 4.9 EU Market Breakdown by Leading Nation: EU Market Shares (%), Global Market Shares (%) and Revenues ($m), 2028
Table 4.10 EU Market, Leading Five National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2017-2028
Table 4.11 German Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2017-2028
Table 4.12 French Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2017-2028
Table 4.13 UK Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2017-2028
Table 4.14 Spanish Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
Table 4.15 Italian Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
Table 4.16 Japanese Cell-Based Assays Market Forecast: Revenues ($m), 2017-2028
Table 4.17 BRIC Countries Breakdown by Nation: BRIC market Shares (%), Global Market Shares (%) and Revenues ($m), 2017
Table 4.18 BRIC Countries Breakdown by Nation: EU market Shares (%), Global Market Shares (%) and Revenues ($m), 2023
Table 4.19 BRIC Countries Breakdown by Nation: EU market Shares (%), Global Market Shares (%) and Revenues ($m), 2028
Table 4.20 BRIC National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2017-2028
Table 4.21 Chinese National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2017-2028
Table 4.22 Indian National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2017-2028
Table 4.23 Russian National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2017-2028
Table 4.24 Brazilian National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2017-2028
Table 5.1 DiscoverX: Company Profile
Table 5.2 DiscoverX: Cell-based Assay Product Portfolio
Table 5.3 Thermo Fisher Scientific, Inc.: Company Profile
Table 5.4 Thermo Fisher Scientific, Inc.: Cell-based Assay Product Portfolio
Table 5.5 Cell Assay Innovations, Inc.: Company Profile
Table 5.6 Cell Assay Innovations, Inc.: Cell-based Assay Product Portfolio
Table 5.7 InSphero AG: Company Profile
Table 5.8 InSphero AG: Cell-based Assay Product Portfolio
Table 5.9 QGel SA.: Company Profile
Table 5.10 QGel SA.: Cell-based Assay Product Portfolio
Table 5.11 Becton, Dickinson and Company: Company Profile
Table 5.12 Becton, Dickinson and Company: Cell-based Assay Product Portfolio
Table 5.13 Promega Corporation: Company Profile
Table 5.14 Promega Corporation: Cell-based Assay Product Portfolio
Table 5.15 BioVision, Inc.: Company Profile
Table 5.16 BioVision, Inc.: Cell-based Assay Product Portfolio
Table 5.17 Marin Biologic Laboratories: Company Profile
Table 5.18 Marin Biologic Laboratories: Cell-based Assay Product Portfolio
Table 5.19 Molecular Devices, LLC.: Company Profile
Table 5.20 Molecular Devices, LLC.: Cell-based Assay Product Portfolio
Table 5.21 Porsolt: Company Profile
Table 5.22 Porsolt: Cell-based Assay Product Portfolio
Table 5.23 CYTOO SA: Company Profile
Table 5.24 CYTOO SA: Cell-based Assay Product Portfolio
Table 5.25 Pharmaceutical Product Development, LLC.: Company Profile
Table 5.26 Pharmaceutical Product Development, LLC.: Cell-based Assay Product Portfolio
Table 5.27 ProQinase GmbH: Company Profile
Table 5.28 ProQinase GmbH: Cell-based Assay Product Portfolio
Table 5.29 Charles River Laboratories International, Inc.: Company Profile
Table 5.30 Charles River Laboratories International, Inc.: Cell-based Assay Product Portfolio
Table 5.31 BioAgilytix Labs: Company Profile
Table 5.32 BioAgilytix Labs: Cell-based Assay Product Portfolio]
Table 5.33 SGS Group: Company Profile
Table 5.34 SGS Group: Cell-based Assay Product Portfolio
Table 5.35 Perkin Elmer Inc.: Company Profile
Table 5.36 Perkin Elmer Inc.: Cell-based Assay Product Portfolio
Table 5.37 General Electric: Company Profile
Table 6.1 Selected Companies with Involvement in Stem Cell-Based Assays
Table 6.2 Selected Companies Offering Label-Free Assay Systems
Abcam
Accuri Cytometers, Inc.
Affymetrix, Inc.
Agilent Technologies
Applied Biosystems
Ascendance Biotechnology
AstraZeneca
ATCC
AXAM
Axiogenesis AG
B’SYS GmbH
BASF
Bayer
Becton, Dickinson and Company
Becton Dickinson Asia Limited
Becton Dickinson Biosciences
BioAgilytix Labs
BioCity
Biocroi
Biofungitek
BioIVT
Biotechnology Industry Research Assistance Council (BIRAC)
BioVision, Inc.
BMG LABTECH GmbH
C.R. Bard
Caliper Life Sciences, Inc.
Cambridge Research & Instrumentation, Inc.
Cell Assay Innovations (CAI)
Cell Biolabs
Charles River Germany GmbH & Co. KG
Charles River Holdings LLC
Charles River Laboratories
Charles River Laboratories International, Inc.
Charles River Laboratories, Inc.
Charles River Nederland BV
Charles River UK Limited
Cisbio Bioassays
Cohesive Technologies Inc.
Contextual Genomics
CYTOO SA
Daiichi Sankyo Company Limited
Danaher Corporation
Department of Biotechnology (DBT)
DiscoverX
Dr. Reddy’s Laboratories
Draconis Pharma
Eurofins Scientific S.E.
EUROIMMUN US Inc.
Food and Drug Administration (FDA)
Fisher Scientific
FLUOFARMA
Foundation Top Institute Pharma
Fulcrum Therapeutics
GE Healthcare
GE Healthcare AS
GE Healthcare Bio-Sciences AB
GE Healthcare BVBA
GE Healthcare European Holdings SARL
GE Healthcare Japan Corporation
GE Healthcare USA Holding LLC
General Electric Company
GIMDx, Inc.
Guangzhou Improve Medical Instruments
HD Biosciences Co., Ltd.
Helsinki Institute of Life Science
Icagen, Inc.
Idengene SA
IncellDx, Inc
Indian Institute of Chemical Technology (IICT)
Innoprot
InSphero AG
IntelliCyt
Interchim
Invitrogen
Janssen
Jubilant Biosys
Labcyte Inc.
Lead Discovery Centre GmbH
Likarda
Luxcel Biosciences Ltd
Marin Biologic Laboratories
Mayflower Biosciences
Merck KGaA
Metrion Biosciences Ltd
Molecular Devices, LLC
NanoString Technologies, Inc.
Ncardia
NEOMED Institute
Netherlands Cancer Institute
Neuron BioServices
NovaScreen Biosciences Corporation
NovaWave Technologies, Inc.
On Target Co., Ltd
Oncotest
Pelago Bioscience
Perkin Elmer Inc.
Phadia GmbH
Pharmaceutical Product Development (PPD)
Pharmaceutical Product Development, LLC.
Phenomics Discovery Initiative (PDi)
Pluriomics B.V.
Porsolt
Porsolt and Fluofarma acquisition
Premas Lifescience
Promega Corporation
ProQinase GmbH
QGel SA.
Riken Genesis
Russian Federation
Sanofi
Science Exchange
SGS Australia
SGS Belgium NV
SGS Central America S.A.
SGS Group
SGS North America Inc.
Skolkovo Foundation
StemTek therapeutics
Sygnature Discovery
Syncom
Sysmex Corporation
Systems and Reagents Inc.
Takeda Pharmaceutical Company Limited
Tecan Group Ltd.
The Structural Genomics Consortium
Thermo Electron A/S
Thermo Fisher Scientific (and Affymetrix acquisition)
Thermo Fisher Scientific Operating Company LLC
Thermo Fisher Scientific Senior Financing LLC
Thermo Scientific
Tufts Center for the Study of Drug Development
UCB
Unity Lab Services
Valneva SE
VitoTag Biosciences
Xenogen Corporation
ZF BioLabs
ZF Biotox
List of Organisations mentioned in the report
All India Institute of Medical Sciences (AIIMS)
American Society of Cell Biology (ASCB)
AMR Centre (AMRC)
Association of Research-Based Pharmaceutical Companies
Biotechnology Industry Research Assistance Council (BIRAC)
Department of Biotechnology (DBT)
Foundation Top Institute Pharma
Helsinki Institute of Life Science
Imperial College London
Indian Institute of Chemical Technology (IICT)
Innovative Medicines Initiative (IMI)
nstitute for Chemical Sciences in Rennes
Institute for In Vitro Sciences, Inc. (IIVS)
Institute for Molecular Medicine Finland (FIMM)
Karolinska Institutet
Medical Research Council (MRC) Centre for Regenerative Medicine (CRM)
Memorial Sloan Kettering Cancer Center (MSK)
National Health Service (NHS)
National Phenotypic Screening Centre (NPSC)
NEOMED Institute
Netherlands Cancer Institute
Oxford University
Pharmaceutical Research and Manufacturers of America (PhRMA)
Phenomics Discovery Initiative (PDi)
Russian Federation
Science Exchange
Skolkovo Foundation
Tufts Center for the Study of Drug Development
Unity Lab Services
University of Dundee
University of Edinburgh
University of Helsinki
University of Oxford
World Health Organization (WHO)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
